In ER-deficient mammary tumor cells, isoflavone selectively inhibited nuclear NFkB transduction of specific target gene through a new mechanism via depressing upstream Erk and Mek activities [58, Fig. 2-(7)]. Here, MAP2K7 is linked to breast cancer.